Romuald Seizeur

Prof. Dr. Romuald Seizeur

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 June 2013 in Surgical and Radiologic Anatomy
Verified
Journal Article
Closed access
PDF file
RSRomuald Seizeur
Romuald Seizeur
EMElsa Magro
Elsa Magro
SPSylvain Prima
Sylvain Prima
NWNicolas Wiest-Daesslé
Nicolas Wiest-Daesslé
CMCamille Maumet
Camille Maumet
XMXavier Morandi
Xavier Morandi

2 August 2012 in Neuroradiology
Verified
Journal Article
Closed access
PDF file
EMElsa Magro
Elsa Magro
TMTristan Moreau
Tristan Moreau
RSRomuald Seizeur
Romuald Seizeur
BGBernard Gibaud
Bernard Gibaud
XMXavier Morandi
Xavier Morandi

29 September 2016 in British Journal Of Neurosurgery
Verified
Journal Article
Closed access
RSRomuald Seizeur
Romuald Seizeur
FAFrancis Abed-Rabbo
Francis Abed-Rabbo
SOSami Obaid
Sami Obaid
PSPhilippe Saliou
Philippe Saliou
ASAlexandre Simon
Alexandre Simon
EMElsa Magro
Elsa Magro
Objective: Chronic subdural haematomas (CSDH) is a common pathology that usually affects the elderly population. The incidence of CSDH has recently been increasing with the expansion of the aging population. The objective of our study was to evaluate the outcome following surgical drainage of CSDH in elderly patients. Materials and methods: We performed a retrospective analysis of 455 consecutive patients with CSDHs over a 5-year period. Among them, all 121 patients older than 80-year old were included in the study. Clinical status, comorbidities, type of surgical technique and outcome were analyzed. Outcome at last follow-up was measured using the Markwalder grading score and the Glasgow outcome scale. Results: Patients ranged from 80- to 94-year old with a median age of 84 years (range 80–94). Ninety-eight percent of patients were surgically treated by a small burr hole under assisted local anaesthesia. About 69.2% of patients improved post-operatively. The mortality rate was 6.8%. Conclusion: CSDH is a common pathology in the elderly population. Patients with CSDHs often have comorbodities that need to be considered in deciding whether surgical treatment is indicated. When surgery is elected, small craniostomy techniques performed under assisted local anesthesia is safe and should be favored in this frail population.

3 December 2024 in Clinical Cancer Research
Verified
Journal Article
Open access
ALAudrey-Anne Lamoureux
Audrey-Anne Lamoureux
MFMichael J. Fisher
Michael J. Fisher
LLLauriane Lemelle
Lauriane Lemelle
EPElke Pfaff
Elke Pfaff
PAPouneh Amir-Yazdani
Pouneh Amir-Yazdani
Sébastien PerreaultSébastien Perreault
Sébastien Perreault
Purpose: Tropomyosin receptor kinase (TRK) fusions are detected in less than 2% of central nervous system tumors. There are limited data on the clinical course of affected patients. Experimental Design: We conducted an international retrospective cohort study of patients with TRK fusion–driven central nervous system tumors. Results: A total of 119 patients were identified. The median age at the time of diagnosis was 4.5 years. The majority were reported to have a histology consistent with a diagnosis of high-grade glioma (HGG; 57.1%) followed by low-grade glioma (LGG; 27.7%). Pediatric patients had a better prognosis, with a median overall survival of 185.5 months compared with 24.8 months in adults (P < 0.0001). Patients with LGG also had a better outcome when compared with HGG (P = 0.0012). The objective response was 68.8% with larotrectinib compared with 38.1% for nontargeted treatment. Conclusions: Children with LGG had a favorable outcome compared with adult glioma and HGG. TRK inhibitors seem to improve tumor control.

3 February 2023 in Cancers
Verified
Journal Article
Open access
PDF file
RTRuben Touati
Ruben Touati
VBVincent Bourbonne
Vincent Bourbonne
GDGurvan Dissaux
Gurvan Dissaux
GGGaëlle Goasduff
Gaëlle Goasduff
OPOlivier Pradier
Olivier Pradier
FLFrançois Lucia
François Lucia
Purpose: To evaluate the efficacy and safety of a second course of stereotactic radiotherapy (SRT2) treatment for a local recurrence of brain metastases previously treated with SRT (SRT1), using the Hypofractionated Treatment Effects in the Clinic (HyTEC) reporting standards and the European Society for Radiotherapy and Oncology guidelines. Methods: From December 2014 to May 2021, 32 patients with 34 brain metastases received salvage SRT2 after failed SRT1. A total dose of 21 to 27 Gy in 3 fractions or 30 Gy in 5 fractions was prescribed to the periphery of the PTV (99% of the prescribed dose covering 99% of the PTV). After SRT2, multiparametric MRI, sometimes combined with 18F-DOPA PET-CT, was performed every 3 months to determine local control (LC) and radionecrosis (RN). Results: After a median follow-up of 12 months (range: 1–37 months), the crude LC and RN rates were 68% and 12%, respectively, and the median overall survival was 25 months. In a multivariate analysis, the performance of surgery was predictive of a significantly better LC (p = 0.002) and survival benefit (p = 0.04). The volume of a normal brain receiving 5 Gy during SRT2 (p = 0.04), a dose delivered to the PTV in SRT1 (p = 0.003), and concomitant systemic therapy (p = 0.04) were associated with an increased risk of RN. Conclusion: SRT2 is an effective approach for the local recurrence of BM after initial SRT treatment and is a potential salvage therapy option for well-selected people with a good performance status. Surgery was associated with a higher LC.

25 September 2013 in Surgical and Radiologic Anatomy
Verified
Journal Article
Closed access
PDF file
EMElsa Magro
Elsa Magro
BSBernard Sénécail
Bernard Sénécail
JGJean-Christophe Gentric
Jean-Christophe Gentric
ZAZarrin Alavi
Zarrin Alavi
OPOlivier Palombi
Olivier Palombi
RSRomuald Seizeur
Romuald Seizeur